EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering Secretory (S)IgA to Facilitate Affinity Purification for Large Scale Downstream Processing

Tim H Szeto, Julian K-C Ma

Biotechnology Journal · 2026-05 · 21 (5)

DOI: 10.1002/biot.70245 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, online erschienen am 28.05.2026. Verfasst von Tim H Szeto und 1 weiteren Autor:innen. Beteiligte Einrichtung: Hotung Molecular Immunology Laboratory, Institute for Infection and Immunity, School of Health and Medical Sciences, City St. George's University of …. Hauptthemen laut MEDLINE: Chromatography, Affinity, Protein Engineering, Immunoglobulin A, Secretory, Antibodies, Monoclonal. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Secretory (S)IgA class antibodies play a vital role in first line immunological defence at mucosal surfaces. Passive immunisation with monoclonal SIgA antibodies could offer a completely novel application for a biologics market currently dominated by systemic IgG class monoclonal antibodies. Recent advances have made large scale manufacture of SIgA mAbs feasible, but downstream affinity purification remains a hurdle because IgA antibodies usually have poor affinity for Protein A, the most widely used affinity ligand for antibodies. This research addresses this problem by engineering chimaeric secretory component (SC), containing IgG Fc domains (CH 2 ─CH 3 ) which confer Protein A binding. SC is a component of SIgA and consists of five immunoglobulin‐like domains. We demonstrate that expressing recombinant monoclonal SIgA with SC domains D2–D3 or D3–D4 replaced by IgG Fc domains (CH 2 ─CH 3 ) enables Protein A affinity purification of SIgA, without affecting antibody assembly or antigen binding functionality. Inserting the Protein A binding site into SC, results in purification of SIgA and free SC, which could then be separated according to size, but importantly not SIgA assembly intermediates such as dimeric IgA, that has a similar molecular size to SIgA. The use of SC‐Fc fusions could streamline SIgA mAb purification and unlock their clinical potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromatography, AffinityProtein EngineeringImmunoglobulin A, SecretoryAntibodies, MonoclonalAnimalsImmunoglobulin Fc FragmentsStaphylococcal Protein ARecombinant Fusion ProteinsHumansRecombinant Proteins

Stichwörter der Autor:innen

Protein Aantibody engineeringsecretory component

Substanzen

Immunoglobulin A, SecretoryAntibodies, MonoclonalImmunoglobulin Fc FragmentsStaphylococcal Protein ARecombinant Fusion ProteinsRecombinant Proteins

Autor:innen und Institutionen

  • Hotung Molecular Immunology Laboratory, Institute for Infection and Immunity, School of Health and Medical Sciences, City St. George's University of London, London, UK.

Zitieren

APA

Szeto, T. H., & Ma, J. K. (2026). Engineering Secretory (S)IgA to Facilitate Affinity Purification for Large Scale Downstream Processing. Biotechnology Journal, 21(5). https://doi.org/10.1002/biot.70245

Vancouver

Szeto TH, Ma JK. Engineering Secretory (S)IgA to Facilitate Affinity Purification for Large Scale Downstream Processing. Biotechnology Journal. 2026;21(5). doi:10.1002/biot.70245

BibTeX
@article{Szeto2026,
  author = {Szeto, Tim H and Ma, Julian K-C},
  title = {Engineering Secretory (S)IgA to Facilitate Affinity Purification for Large Scale Downstream Processing},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {5},
  doi = {10.1002/biot.70245}
}
Kostenlos starten →